Drug intelligence / Profile preview

umbilical cord mesenchymal stem cells (Arugula Sciences)

Development stage
Preclinical
Lead developer
Arugula Sciences
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intratracheal, Intraperitoneal, Intrathecal, Intraarticular, Intradiscal, Intracoronary
01

Overview

Arugula Sciences is developing umbilical cord-derived mesenchymal stem cells (UC-MSCs) as a cell therapy for the treatment of chronic inflammatory and degenerative diseases. These cells, also referred to as Medicinal Signaling Cells, are sourced from the umbilical cord, which is recognized for its superior therapeutic potential and robust manufacturing characteristics compared to mesenchymal stem cells (MSCs) derived from other sources like bone marrow or adipose tissue. The therapy functions through immunomodulation and regenerative mechanisms, secreting bioactive factors that regulate the immune system and promote the repair of damaged tissues. Currently in the preclinical stage, the program is being prepared for future FDA clinical trials.

Other names
Medicinal Signaling Cells

Beyond the preview

Go deeper on umbilical cord mesenchymal stem cells (Arugula Sciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord mesenchymal stem cells (Arugula Sciences).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call